Quick Links

Alexandra de Pokomandy

alexandra [dot] depokomandy [at] mcgill [dot] ca (Alexandra de Pokomandy)alexandra [dot] depokomandy [at] mcgill [dot] ca (, MDCM, MSc)

Assistant Professor, McGill University Health Centre

Research Interests: Dr. Alexandra de Pokomandy MDCM MSc, is an assistant professor at the McGill University Health Center and a family physician specialized in HIV patient care since 2003, currently practicing at the Immunodeficiency Service of the Montreal Chest Institute. She completed a Post-Doctoral fellowship in HIV research with the CIHR Canadian HIV Trials Network in 2007 and a Master of Science degree in Epidemiology at McGill University in 2009.   She is the recipient of a FRSQ Clinical Research Scholarship Junior 1 (Chercheur Boursier Clinicien Junior 1), for 2011–2015 and is a member of the scientific committee of the FRSQ network “AIDS and Infectious Disease” (Sida-Maladies Infectieuses). Her main interests of research are in cancer related to human papillomavirus (HPV) affecting people living with HIV (particularly regarding the potential prevention of anal cancer), HIV-positive women’s health, and HIV integrated health care. Her work as a physician and researcher aims to recognize patient health concerns and make improvements to clinical practices that will benefit HIV-positive individuals.

Keywords: Human Papillomavirus (HPV), HIV, Cancer, Women's health

List of Publications:
(Please note that the access to publications offered via Scopus and Pubmed may not reflect exactly the scope of our researcher's publications, can be overrepresented with same name researchers working in the same field)

Via Scopus

Via Pubmed

Research Grants

Canadian HIV Women’s Sexual and Reproductive Health Cohort Study, a Canadian Observational Cohort (CANOC) Affiliated Study. CIHR. Mona Loutfy, Alexandra de Pokomandy et al. $1,192,490 (2011-2016)

Conséquences du virus du papillome humain chez la population infectée par le VIH. FRQS. Principal Investigator. $30,000 (2011-2014)

Cohorte VIH-VPH. FRSQ. Principal Investigator. $60,000 (2011-2013)

Is human papillomavirus causing an epidemic of anal dysplasia in HIV-positive women? CIHR. Principal Investigator. 100,000$ (1st bridge funding) (2011-2012)

Is human papillomavirus causing an epidemic of anal dysplasia in HIV-positive women? CIHR. Principal Investigator. 100,000$ (2nd bridge funding) (2011-2012)

Le VIH/sida et des comorbidités. CIHR. Jose Coté, Alexandra de Pokomandy et al. $99,956 (2011-2012)

Understanding virological and host determinants of HIV disease progression in a cohort of slow progressors. CIHR. Cécile Tremblay, Alexandra de Pokomandy et al. $983,939 (2009-2014)